» Articles » PMID: 19043361

The Expressions of Fas and Caspase-3 in Human Glaucomatous Optic Nerve Axons

Overview
Journal Med Sci Monit
Date 2008 Dec 2
PMID 19043361
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glaucoma is a chronic neurodegeneration of the optic nerve and one of the leading causes of vision loss in the world among the aging. Recent data suggest an important role for Fas receptor- and caspase-3-mediated apoptosis in the pathophysiology of glaucoma. In this study, Fas receptor and caspase-3 immunoexpression in the optic nerve axons of eyeballs with absolute glaucoma and eyes enucleated following extensive trauma were compared.

Material/methods: A series of 25 eyeballs were examined and enucleated during the period of 1994-2005. Seventeen eyeballs were removed from patients with absolute glaucoma who suffered from severe ophthalmalgia and 8 eyeballs were enucleated because of extensive injury on the day of injury or one day thereafter. The samples were obtained from the retrolaminar region of the optic nerve head and evaluated histopathologically. Immunohistochemistry was performed using polyclonal antibodies and the LSAB technique to determine Fas and caspase-3 expression.

Results: The percentages of positive Fas receptor and caspase-3 immunohistochemical staining were higher in the axons with absolute glaucoma than in the trauma group (p=0.0084 for Fas, p=0.0322 for caspase-3).

Conclusions: The results indicate that the apoptosis markers Fas receptor and caspase-3 might play a significant role in glaucoma neuropathy at the stage of absolute glaucoma.

Citing Articles

Apoptosis in glaucoma: A new direction for the treatment of glaucoma (Review).

Xia Q, Zhang D Mol Med Rep. 2024; 29(5).

PMID: 38516770 PMC: 10975112. DOI: 10.3892/mmr.2024.13207.


Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials.

Zhao W, Fan C, Hu X, Ban X, Wan H, He Y Cell Mol Neurobiol. 2023; 43(7):3161-3178.

PMID: 37338781 PMC: 11410022. DOI: 10.1007/s10571-023-01373-1.


Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients.

Andres-Blasco I, Gallego-Martinez A, Machado X, Cruz-Espinosa J, Di Lauro S, Casaroli-Marano R Int J Mol Sci. 2023; 24(9).

PMID: 37175931 PMC: 10179600. DOI: 10.3390/ijms24098227.


Neuroprotection in Glaucoma: Old and New Promising Treatments.

Rusciano D, Pezzino S, Mutolo M, Giannotti R, Librando A, Pescosolido N Adv Pharmacol Sci. 2019; 2017:4320408.

PMID: 30723498 PMC: 5664381. DOI: 10.1155/2017/4320408.


Modulation of the Immune System for the Treatment of Glaucoma.

Bell K, Und Hohenstein-Blaul N, Teister J, Grus F Curr Neuropharmacol. 2017; 16(7):942-958.

PMID: 28730968 PMC: 6120111. DOI: 10.2174/1570159X15666170720094529.